Dr Fabian Kreimendahl
Medical Evidence Biostatistics Manager
The Janssen Pharmaceutical Companies of Johnson & Johnson
Fabian Kreimendahl (PhD) has over ten years of experience in the pharmaceutical industry. A biostatistician by training, his academic career includes research visits to Utrecht, Montréal, Dresden and Cologne.
He has held several roles where he led and coordinated biostatistics and data management in clinical research. In his current role at Johnson & Johnson he is responsible for biostatistics and data management of clinical trials across indications with a focus on oncology and dermatology.
Prior to joining Johnson & Johnson, Fabian held the position of Director Biostatistics for the BU Allergology at Merck where he successfully accompanied clinical research programs to achieve market authorization.
Fabian codes himself and has a deeply rooted understanding of advanced analytics for clinical as well as real world data. He is an ambassador of the efficient use of Machine Learning and Artificial Intelligence as well as the smart use of disruptive technologies in pharmaceutical research and likes to challenge the status quo.